3 papers
cs.DL2013
Big Pharma, little science? A bibliometric perspective on big pharma's R&D decline
Ismael Rafols, Michael M. Hopkins, Jarno Hoekman +4
There is a widespread perception that pharmaceutical R&D is facing a productivity crisis characterised by stagnation in the numbers of new drug approvals in the face of increasing…
cs.DL2011
How journal rankings can suppress interdisciplinary research. A comparison between Innovation Studies and Business & Management
Ismael Rafols, Loet Leydesdorff, Alice O'Hare +2
This study provides quantitative evidence on how the use of journal rankings can disadvantage interdisciplinary research in research evaluations. Using publication and citation dat…
physics.soc-ph2009
The missing link in nanomaterials governance: industrial dynamics and downstream policies
Ismael Rafols, Patrick van Zwanenberg, Molly Morgan +2
In this article we explore the analytical and policy implications of widening the governance of nanomaterials from the focus on risk regulation to a broader focus on the governance…